161 related articles for article (PubMed ID: 35281945)
1. Artificial Intelligence Algorithm-Based Computerized Tomography Image Features Combined with Serum Tumor Markers for Diagnosis of Pancreatic Cancer.
Qiao Z; Ge J; He W; Xu X; He J
Comput Math Methods Med; 2022; 2022():8979404. PubMed ID: 35281945
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of the value of imaging, serum markers and their combination in the diagnosis of pancreatic carcinoma in symptomatic patients.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
Anticancer Res; 1992; 12(6B):2309-14. PubMed ID: 1295478
[TBL] [Abstract][Full Text] [Related]
3. Multimodal MRI Analysis of Cervical Cancer on the Basis of Artificial Intelligence Algorithm.
Wang B; Zhang Y; Wu C; Wang F
Contrast Media Mol Imaging; 2021; 2021():1673490. PubMed ID: 34858113
[TBL] [Abstract][Full Text] [Related]
4. Application of 18F-FDG PET/CT combined with carbohydrate antigen 19-9 for differentiating pancreatic carcinoma from chronic mass-forming pancreatitis in Chinese elderly.
Gu X; Liu R
Clin Interv Aging; 2016; 11():1365-1370. PubMed ID: 27729779
[TBL] [Abstract][Full Text] [Related]
5. CA 242 is a new tumor marker for pancreatic cancer.
Röthlin MA; Joller H; Largiadèr F
Cancer; 1993 Feb; 71(3):701-7. PubMed ID: 8431849
[TBL] [Abstract][Full Text] [Related]
6. CA 494--a new tumor marker for the diagnosis of pancreatic cancer.
Friess H; Büchler M; Auerbach B; Weber A; Malfertheiner P; Hammer K; Madry N; Greiner S; Bosslet K; Beger HG
Int J Cancer; 1993 Mar; 53(5):759-63. PubMed ID: 8449599
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
Br J Cancer; 1994 Mar; 69(3):562-5. PubMed ID: 8123488
[TBL] [Abstract][Full Text] [Related]
8. Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology.
Ferri MJ; Saez M; Figueras J; Fort E; Sabat M; López-Ben S; de Llorens R; Aleixandre RN; Peracaula R
PLoS One; 2016; 11(1):e0147214. PubMed ID: 26808421
[TBL] [Abstract][Full Text] [Related]
9. Serum CA 242: the search for a valid marker of pancreatic cancer.
Ventrucci M; Ubalducci GM; Cipolla A; Panella MA; Ligabue A
Clin Chem Lab Med; 1998 Mar; 36(3):179-84. PubMed ID: 9589807
[TBL] [Abstract][Full Text] [Related]
10. Establishment and application of an artificial intelligence diagnosis system for pancreatic cancer with a faster region-based convolutional neural network.
Liu SL; Li S; Guo YT; Zhou YP; Zhang ZD; Li S; Lu Y
Chin Med J (Engl); 2019 Dec; 132(23):2795-2803. PubMed ID: 31856050
[TBL] [Abstract][Full Text] [Related]
11. New tumor-associated antigen SC6 in pancreatic cancer.
Liu MP; Guo XZ; Xu JH; Wang D; Li HY; Cui ZM; Zhao JJ; Ren LN
World J Gastroenterol; 2005 Dec; 11(48):7671-5. PubMed ID: 16437697
[TBL] [Abstract][Full Text] [Related]
12. Two-stage deep learning model for fully automated pancreas segmentation on computed tomography: Comparison with intra-reader and inter-reader reliability at full and reduced radiation dose on an external dataset.
Panda A; Korfiatis P; Suman G; Garg SK; Polley EC; Singh DP; Chari ST; Goenka AH
Med Phys; 2021 May; 48(5):2468-2481. PubMed ID: 33595105
[TBL] [Abstract][Full Text] [Related]
13. Automatic segmentation of lung tumors on CT images based on a 2D & 3D hybrid convolutional neural network.
Gan W; Wang H; Gu H; Duan Y; Shao Y; Chen H; Feng A; Huang Y; Fu X; Ying Y; Quan H; Xu Z
Br J Radiol; 2021 Oct; 94(1126):20210038. PubMed ID: 34347535
[TBL] [Abstract][Full Text] [Related]
14. Application values of detection of serum CA199, CA242 and CA50 in the diagnosis of pancreatic cancer.
Lei XF; Jia SZ; Ye J; Qiao YL; Zhao GM; Li XH; Chang H
J Biol Regul Homeost Agents; 2017; 31(2):383-388. PubMed ID: 28685541
[TBL] [Abstract][Full Text] [Related]
15. CA 50 compared with CA 19-9 as a serum tumour marker for pancreatic carcinoma.
Pasquali C; Sperti C; D'Andrea AA; Costantino V; Filipponi C; Pedrazzoli S
Ital J Gastroenterol; 1994 May; 26(4):169-73. PubMed ID: 7949259
[TBL] [Abstract][Full Text] [Related]
16. Tumor markers in pancreatic cancer: a comparative clinical study between CEA, CA 19-9 and CA 50.
Molina LM; Díez M; Cava MT; Maestro ML; Ortega MD; Mendíz JG; Prego A; De Diego JA; Balibrea JL
Int J Biol Markers; 1990; 5(3):127-32. PubMed ID: 2286776
[TBL] [Abstract][Full Text] [Related]
17. Segmentation of pancreatic ductal adenocarcinoma (PDAC) and surrounding vessels in CT images using deep convolutional neural networks and texture descriptors.
Mahmoudi T; Kouzahkanan ZM; Radmard AR; Kafieh R; Salehnia A; Davarpanah AH; Arabalibeik H; Ahmadian A
Sci Rep; 2022 Feb; 12(1):3092. PubMed ID: 35197542
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
Br J Cancer; 1992 May; 65(5):731-4. PubMed ID: 1316775
[TBL] [Abstract][Full Text] [Related]
19. Liver tumor segmentation based on 3D convolutional neural network with dual scale.
Meng L; Tian Y; Bu S
J Appl Clin Med Phys; 2020 Jan; 21(1):144-157. PubMed ID: 31793212
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
